NCT02144584View on ClinicalTrials.gov

Memantine for Enhanced Stroke Recovery

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Ischemic StrokeUpper Extremity Weakness
Interventions
DRUG

Memantine XR

The active drug will be encapsulated by the University of Utah Research Pharmacy to maintain blinding.

DRUG

Placebo (for memantine)

Placebo to be capsuled to look identical to active drug (memantine)

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER